Because only the 73 TP53 hot spot mutations from among more than 1000 mutation sites listed in the COSMIC database were targeted by the Ion AmpliSeq Cancer Primer Pools [24] and, moreover, low tumour-cellularity specimens were used, the TP53 alterations may have been underestimated in our study. This evidence concerns the gene TP53 and neoplasm.